WellsRX Sdn Bhd (“WellsRX”) refers to recent misinformation and circulating allegations in relation to legal proceedings involving its CEO, Farah Sabryna Nasarudin.
For clarity, the matter has been addressed before the court on 17th April 2026, and the individual was discharged, with no conviction, no finding of guilt, and no determination of wrongdoing by any court of law.
Any suggestion of wrongdoing or impropriety is inaccurate and unsupported by any judicial finding.
WellsRX will take all necessary steps to protect its reputation and interests against any false or misleading statements.
WellsRX remains fully operational and continues to perform all contractual obligations without disruption. The company maintains strict standards of professional integrity, governance, and compliance across all its operations.
Relevant stakeholders have been formally apprised of the matter and its status through appropriate channels.
Stakeholders are advised to rely solely on verified facts and official court outcomes.
For any clarification on legal matters, all enquiries should be directed to our legal counsel, Mak LK & Co (telephone: +603-2284 7778 / +603-2201 1886, email: [email protected]).